Cover Story
The American Cancer Society said that Karen E. Knudsen “announced her desire to transition” from her role as CEO of the 111-year-old charity in order to pursue “the next phase of her strategy to accelerate progress against cancer.”
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer” - ODAC votes overwhelmingly in support of PD-L1 expression as predictive biomarker for efficacy of checkpoint inhibitors
Vote applies across drugs and indications - Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?
- NCI-designated Basic Laboratory Cancer Centers get research done—efficiently
- Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer
- Jeffrey Weber on his career, mentors: “Never ever ever ever blow your cool.”